戊型肝炎疫苗。
Hepatitis E vaccine.
机构信息
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Rae Bareilly Road, Lucknow, 226 014, India.
出版信息
Hepatol Int. 2008 Sep;2(3):308-15. doi: 10.1007/s12072-008-9071-4. Epub 2008 Apr 10.
Abstract
Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2 billion people live in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant subunit vaccines based on the viral capsid protein. This review summarizes these efforts.
摘要
戊型肝炎是一种在世界资源匮乏地区新出现的疾病。据估计，约有 20 亿人生活在这种疾病流行的地区。由于无法重复培养戊型肝炎病毒，因此无法开发传统的活疫苗或灭活疫苗。然而，基于病毒衣壳蛋白的重组亚单位疫苗的开发和试验已经取得了重大进展。本文综述了这些努力。
相似文献
1
Hepatitis E vaccine.
Hepatol Int. 2008 Sep;2(3):308-15. doi: 10.1007/s12072-008-9071-4. Epub 2008 Apr 10.
2
Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine.
J Infect Dis. 1995 Mar;171 Suppl 1:S33-9. doi: 10.1093/infdis/171.supplement_1.s33.
3
Possible approaches to develop vaccines against hepatitis A.
Vaccine. 1992;10 Suppl 1:S48-52. doi: 10.1016/0264-410x(92)90542-r.
4
Foot-and-mouth disease vaccines: progress and problems.
Expert Rev Vaccines. 2016 Jun;15(6):783-9. doi: 10.1586/14760584.2016.1140042. Epub 2016 Jan 22.
5
Inactivated and live bivalent fowl adenovirus (FAdV8b + FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
Vaccine. 2018 Jan 29;36(5):744-750. doi: 10.1016/j.vaccine.2017.12.047. Epub 2017 Dec 29.
6
Hepatitis E vaccines: progress and prospects.
Drugs. 2004;64(14):1517-31. doi: 10.2165/00003495-200464140-00002.
7
Hepatitis E: a neglected threat.
Trans R Soc Trop Med Hyg. 2008 Mar;102(3):211-2. doi: 10.1016/j.trstmh.2007.03.014. Epub 2007 Jul 20.
8
Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens.
Avian Dis. 2015 Dec;59(4):518-24. doi: 10.1637/11202-052815-Reg.1.
9
Perspectives of vaccination against hepatitis E.
Intervirology. 2001;44(2-3):162-6. doi: 10.1159/000050043.
10
Toward the development of a hepatitis E vaccine.
Virus Res. 2011 Oct;161(1):93-100. doi: 10.1016/j.virusres.2011.05.008. Epub 2011 May 18.
引用本文的文献
1
Prevalence of Hepatitis E Virus and Its Associated Outcomes among Pregnant Women in China.
Pathogens. 2023 Aug 22;12(9):1072. doi: 10.3390/pathogens12091072.
2
Scientific Opinion on an update on the present knowledge on the occurrence and control of foodborne viruses.
EFSA J. 2011 Jul 14;9(7):2190. doi: 10.2903/j.efsa.2011.2190. eCollection 2011 Jul.
3
Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.
PLoS One. 2015 Apr 13;10(4):e0123400. doi: 10.1371/journal.pone.0123400. eCollection 2015.
4
Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006.
PLoS One. 2014 Oct 31;9(10):e110837. doi: 10.1371/journal.pone.0110837. eCollection 2014.
5
Genetic heterogeneity of swine hepatitis E virus isolates from Yunnan province, China in 2011-2012.
Virol J. 2014 Sep 4;11:162. doi: 10.1186/1743-422X-11-162.
6
Novel hepatitis E like virus found in Swedish moose.
J Gen Virol. 2014 Mar;95(Pt 3):557-570. doi: 10.1099/vir.0.059238-0. Epub 2013 Dec 2.
7
Fatal hepatitis E viral infection in pregnant women in Ghana: a case series.
BMC Res Notes. 2012 Sep 3;5:478. doi: 10.1186/1756-0500-5-478.
8
Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.
J Virol. 2012 Aug;86(15):7880-6. doi: 10.1128/JVI.00610-12. Epub 2012 May 16.
9
The hepatitis E virus ORF3 protein regulates the expression of liver-specific genes by modulating localization of hepatocyte nuclear factor 4.
PLoS One. 2011;6(7):e22412. doi: 10.1371/journal.pone.0022412. Epub 2011 Jul 20.
10
Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF.
Proteome Sci. 2011 Feb 4;9:5. doi: 10.1186/1477-5956-9-5.
本文引用的文献
1
Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Vaccine. 2007 May 30;25(22):4350-60. doi: 10.1016/j.vaccine.2007.03.040. Epub 2007 Apr 9.
2
Safety and efficacy of a recombinant hepatitis E vaccine.
N Engl J Med. 2007 Mar 1;356(9):895-903. doi: 10.1056/NEJMoa061847.
3
A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.
Vaccine. 2005 Apr 22;23(22):2893-901. doi: 10.1016/j.vaccine.2004.11.064.
4
Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid.
J Biol Chem. 2005 Feb 4;280(5):3400-6. doi: 10.1074/jbc.M410361200. Epub 2004 Nov 22.
5
Hepatitis E: an overview and recent advances in vaccine research.
World J Gastroenterol. 2004 Aug 1;10(15):2157-62. doi: 10.3748/wjg.v10.i15.2157.
6
Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
Chin Med Sci J. 2004 Jun;19(2):78-83.
7
An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
Vaccine. 2004 Jun 30;22(20):2578-85. doi: 10.1016/j.vaccine.2003.12.017.
8
Molecular biology and pathogenesis of hepatitis E virus.
Expert Rev Mol Med. 1999 Dec 6;1999:1-16. doi: 10.1017/S1462399499001271.
9
DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration.
Gene Ther. 2004 Apr;11(7):628-35. doi: 10.1038/sj.gt.3302193.
10
Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
J Infect Dis. 2004 Jan 15;189(2):258-64. doi: 10.1086/380801. Epub 2004 Jan 8.
Zotero 插件